GleamWall
中文EN

FEED ENvue Medical, Inc.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · OTC · SEC CIK 1326706 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-17.7%
TTM net income YoY-154.6%
TTM EPS YoY72.9%
Revenue 3-yr CAGR44.2%
Net income 3-yr CAGR—

Margins

Gross margin-26.1%
Operating margin-1,362.7%
Net margin-1,093.6%
FCF margin-609.8%
EBITDA margin-1,313.3%

Returns

ROE-59.1%
ROA-46.9%
ROIC (approx.)-62.7%
Asset turnover0.04x

Leverage & solvency

Liabilities / assets19.9%
Debt / equity0.00x
Current ratio0.66x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.55x
Accruals ratio-20.9%
Payout ratio—
Capex / revenue4.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$2.55M$2.56M
Cost of revenue$2.40M$1.05M
Gross profit$153,000$1.51M
R&D expense$1.76M$909,000
SG&A expense$7.63M$3.46M
Operating income-$22.89M-$3.58M
Interest expense—$135,000
Pretax income-$18.49M-$3.69M
Income tax-$307,000$19,000
Net income-$18.18M-$3.71M
EBITDA-$21.99M-$3.58M
EPS (basic)-26.69-137.30
EPS (diluted)-26.69-137.30
Weighted avg. shares (diluted)628,53426,985
Balance sheet
Cash & equivalents$4.22M$752,000
Receivables$289,000$98,000
Inventory$2.34M$2.19M
Current assets$7.27M$3.33M
PP&E, net$119,000$9,000
Goodwill$29.08M—
Intangibles$4.38M—
Total assets$41.12M$3.63M
Current liabilities$6.66M$2.72M
Total liabilities$7.63M$3.00M
Shareholders' equity$33.50M$627,000
Shares outstanding1.10M37,894
Cash flow statement
Operating cash flow-$9.37M-$2.52M
Capital expenditure$60,000$3,000
Free cash flow-$9.43M-$2.52M
Investing cash flow$88,000-$3,000
Financing cash flow$12.79M$1,000
Depreciation & amortization$897,000$1,000
Stock-based compensation—$356,000

Free plan shows the latest 2 periods; Pro shows all 12 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.